Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition.
Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition.
The UCW Newswire : Financial, Business and Tech NewsCopyright © Louis Velazquez. All Rights Reserved.